Metabolomic signatures of cardiac remodelling and heart failure risk in the community-Reference-Cited by-同舟云学术

Metabolomic signatures of cardiac remodelling and heart failure risk in the community

Published:2020-09-10 Issue:6 Volume:7 Page:3707-3715
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Andersson Charlotte¹²³,Liu Chunyu¹⁴,Cheng Susan¹⁵,Wang Thomas J.⁶,Gerszten Robert E.⁷⁸,Larson Martin G.¹⁴,Vasan Ramachandran S.¹⁹¹⁰

Affiliation:

1. NHBLI and Boston University's Framingham Heart Study Framingham MA USA

2. Department of Medicine, Section of Cardiovascular Medicine, Boston Medical Center Boston University School of Medicine 72 East Concord Street Boston MA 02118 USA

3. Department of Cardiology Herlev and Gentofte Hospital Herlev Denmark

4. Department of Biostatistics Boston University School of Public Health Boston MA USA

5. Smidt Heart Institute Cedars‐Sinai Medical Center Los Angeles CA USA

6. Division of Cardiovascular Medicine Vanderbilt University Medical Center Nashville TN USA

7. Division of Cardiovascular Medicine Beth Israel Deaconess Medical Center Boston MA USA

8. Broad Institute of MIT and Harvard Program in Metabolism Cambridge MA USA

9. Sections of Preventive Medicine and Epidemiology, and Cardiovascular Medicine Boston University School of Medicine Boston MA USA

10. Department of Epidemiology Boston University School of Public Health Boston MA USA

Funder

School of Medicine, Boston University

Evans Medical Foundation

American Heart Association

Fondation Leducq

Foundation for the National Institutes of Health

National Institutes of Health

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12923

Reference57 articles.

1. Cardiac effects of l-thyroxine administration in borderline hypothyroidism

2. Thyroid Function and Left Ventricular Structure and Function in the Framingham Heart Study

3. Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease

4. Effects of thiamine on cardiac function in patients with systolic heart failure: systematic review and metaanalysis of randomized, double‐blind, placebo‐controlled trials;Dinicolantonio JJ;Ochsner J,2013

5. Obesity and the Risk of Heart Failure

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomic profiling identifies novel metabolites associated with cardiac dysfunction;Scientific Reports;2024-09-05

2. Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease;Nature Communications;2024-07-08

3. Broadcasters, receivers, functional groups of metabolites, and the link to heart failure by revealing metabolomic network connectivity;Metabolomics;2024-07-07

4. Using Omics to Identify Novel Therapeutic Targets in Heart Failure;Circulation: Genomic and Precision Medicine;2024-06

5. Metabolomics to predict heart failure development: A new frontier?;European Journal of Heart Failure;2024-05-07